Author
Abbie Lewis
Abbie plays a key role in delivering OneVentures’ marketing, PR, community and branding initiatives, strengthening the firm’s identity and amplifying the visibility of our portfolio companies. Before joining OneVentures, Abbie worked at 89up in London, Europe’s first impact PR agency, where she contributed to global campaigns for NGOs.
09 September 2024
OneVentures
Australian Investment Council announces 2024 investing for growth award winners
Read the full article: Australian Investment Council
investmentcouncil.com.au/site/AIC/Articles/Media-Release/2024/AIC-announces-2024-Investing-for-Growth-Awards.aspx#:~:text=Pacific%20Equity%20Partners%20and%20OneVentures,the%20private%20capital%20investment%20community.
investmentcouncil.com.au/site/AIC/Articles/Media-Release/2024/AIC-announces-2024-Investing-for-Growth-Awards.aspx#:~:text=Pacific%20Equity%20Partners%20and%20OneVentures,the%20private%20capital%20investment%20community.
29 August 2024
Growth Equity
OneVentures raising $200m to fill gap left by corporate venture capital funds
Read the full article: The Australian
theaustralian.com.au/subscribe/news/1/?sourceCode=TAWEB_WRE170_a&dest=https%3A%2F%2Fwww.theaustralian.com.au%2Fbusiness%2Ftechnology%2Foneventures-raising-200m-to-fill-gap-left-by-corporate-venture-capital-funds%2Fnews-story%2Fbd0bb5a86e50e6d662490d434a4c442d&memtype=anonymous&mode=premium&v21=GROUPB-Segment-2-NOSCORE&V21spcbehaviour=append
theaustralian.com.au/subscribe/news/1/?sourceCode=TAWEB_WRE170_a&dest=https%3A%2F%2Fwww.theaustralian.com.au%2Fbusiness%2Ftechnology%2Foneventures-raising-200m-to-fill-gap-left-by-corporate-venture-capital-funds%2Fnews-story%2Fbd0bb5a86e50e6d662490d434a4c442d&memtype=anonymous&mode=premium&v21=GROUPB-Segment-2-NOSCORE&V21spcbehaviour=append
29 November 2023
Healthcare
US FDA Grants the BiVACOR Total Artificial Heart IDE Approval for First-in-Human Early Feasibility Study
Read the full article: Business Wire
businesswire.com/news/home/20231129194008/en/US-FDA-Grants-the-BiVACOR-Total-Artificial-Heart-IDE-Approval-for-First-in-Human-Early-Feasibility-Study
businesswire.com/news/home/20231129194008/en/US-FDA-Grants-the-BiVACOR-Total-Artificial-Heart-IDE-Approval-for-First-in-Human-Early-Feasibility-Study
18 June 2023
Healthcare
Vaxxas opens world-class manufacturing facility to produce needle-free vaccine patch
Read the full article: Vaxxas
businesswire.com/news/home/20230618635444/en/Vaxxas-Opens-World-Class-Manufacturing-Facility-To-Produce-Proprietary-Needle-Free-Vaccine-Patch-For-Late-Stage-Clinical-Trials-and-First-Commercial-Products
businesswire.com/news/home/20230618635444/en/Vaxxas-Opens-World-Class-Manufacturing-Facility-To-Produce-Proprietary-Needle-Free-Vaccine-Patch-For-Late-Stage-Clinical-Trials-and-First-Commercial-Products